139 related articles for article (PubMed ID: 31204286)
1. Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate Kinase.
Makafe GG; Hussain M; Surineni G; Tan Y; Wong NK; Julius M; Liu L; Gift C; Jiang H; Tang Y; Liu J; Tan S; Yu Z; Liu Z; Lu Z; Fang C; Zhou Y; Zhang J; Zhu Q; Liu J; Zhang T
Cell Chem Biol; 2019 Aug; 26(8):1187-1194.e5. PubMed ID: 31204286
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
4. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
[TBL] [Abstract][Full Text] [Related]
5. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
[TBL] [Abstract][Full Text] [Related]
6. Quinoline alkaloids from Lunasia amara inhibit Mycobacterium tuberculosis H37Rv in vitro.
Aguinaldo AM; Dalangin-Mallari VM; Macabeo AP; Byrne LT; Abe F; Yamauchi T; Franzblau SG
Int J Antimicrob Agents; 2007 Jun; 29(6):744-6. PubMed ID: 17399957
[No Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
12. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin lethality against Mycobacterium tuberculosis in the presence and absence of chloramphenicol.
Malik M; Drlica K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2842-4. PubMed ID: 16870782
[TBL] [Abstract][Full Text] [Related]
14. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
15. Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents.
Yang CL; Tseng CH; Chen YL; Lu CM; Kao CL; Wu MH; Tzeng CC
Eur J Med Chem; 2010 Feb; 45(2):602-7. PubMed ID: 19926361
[TBL] [Abstract][Full Text] [Related]
16. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
[TBL] [Abstract][Full Text] [Related]
17. Design of novel quinoline-aminopiperidine derivatives as
Wang J; Zhao C; Tu J; Yang H; Zhang X; Lv W; Zhai H
J Biomol Struct Dyn; 2019 Jul; 37(11):2913-2925. PubMed ID: 30044186
[TBL] [Abstract][Full Text] [Related]
18. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
[TBL] [Abstract][Full Text] [Related]
19. Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors.
Fang C; Lee KK; Nietupski R; Bates RH; Fernandez-Menendez R; Lopez-Roman EM; Guijarro-Lopez L; Yin Y; Peng Z; Gomez JE; Fisher S; Barros-Aguirre D; Hubbard BK; Serrano-Wu MH; Hung DT
Bioorg Med Chem Lett; 2018 Dec; 28(22):3529-3533. PubMed ID: 30316633
[TBL] [Abstract][Full Text] [Related]
20. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
